Utah Stimulating Access to Research in Residency

NIH RePORTER · NIH · R38 · $231,044 · view on reporter.nih.gov ↗

Abstract

Abstract University of Utah Health is the only academic health center in the Intermountain West and has a strong history of knowledge discovery. The proposed Utah Stimulating Access to Research in Residency (Utah StARR) R38 Program will train resident-investigators in Family Medicine, Internal Medicine, Neurology, Medical-Pediatrics, Obstetrics and Gynecology, and Pediatrics to become physician scientists working across a broad spectrum of clinical, translational, community-engaged, and health services research. We will admit up to four trainees per year. The Utah StARR Program will administratively be housed at the Department of Family and Preventive Medicine in the UofU Health and will include collaborative efforts from across the four other participating departments. The program will include three tracks: 1) Clinical and Translational Research Track; 2) Health Services Research Track; and 3) Community-Engagement Research Track and will emphasize training in research methods, career development including scientific writing, and expert faculty mentoring by seasoned NIH and NHLBI researchers. The program’s research curriculum, mentored research, and career development activities will lead to success in transitioning resident-investigators to successful careers as clinician-scientists in primary care-serving and related specialties focused on research targeted to reduce health disparities in cardiovascular and pulmonary and related diseases impacting disadvantaged populations. It is expected that by the end of the program resident investigators will be well positioned to apply for early career research awards, including career development (K-type) awards.

Key facts

NIH application ID
10766246
Project number
5R38HL167282-02
Recipient
UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
Principal Investigator
Margaret B Conroy
Activity code
R38
Funding institute
NIH
Fiscal year
2024
Award amount
$231,044
Award type
5
Project period
2023-02-01 → 2028-01-31